FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to application for production of medication for prevention and/or treatment of radiolesion or lesion of trisubstituted glycerol compound, corresponding to formula where X is selected from phosphate and sulfate; R1 is selected from C16-C20alkyl, R2 is selected from C1-C3alkyl and C1-C3hydroxyalkyl, R3 is selected from hydrogen and C1-C3 alkyl, R4 is selected from C1-C3alkyl and C3-C6cycloalkyl, R5 is selected from hydrogen and methyl, or its enantiomer, or diastereomer, or pharmaceutically acceptable salt, and at least one pharmaceutically acceptable filling agent.
EFFECT: claimed is novel application of known compounds.
12 cl, 3 dwg, 5 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PHARMACOLOGICAL PROTECTION FROM IONIZING RADIATION | 2017 |
|
RU2663465C1 |
USE OF SESQUITERPENE LACTONE COMPOUND IN PREPARING DRUGS FOR RELIEVING RADIATION-INDUCED INJURIES | 2021 |
|
RU2822760C1 |
RADIOPROTECTIVE PHARMACOLOGICAL AGENT | 2020 |
|
RU2733883C2 |
RADIOPROTECTIVE, RADIOMITIGATORY AND RADIOSENSITIZING AGENT BASED ON SODIUM SALT OF AMINODIHYDROPHTHALAZINEDIONE SODIUM (DRUG TAMERON) AND OTHER ALKALI AND ALKALINE EARTH METAL SALTS OF AMINODIHYDROPHTHALAZINEDIONE | 2022 |
|
RU2804886C1 |
AGENT FOR EARLY PATHOGENETIC THERAPY OF ACUTE RADIATION DISEASE | 2003 |
|
RU2281092C2 |
ANTIRADIATION AGENT | 1996 |
|
RU2123348C1 |
PREPARATION FOR TREATING ACUTE RADIATION LESIONS | 2004 |
|
RU2260425C1 |
AGENT FOR EARLY THERAPY OF RADIATION DAMAGES | 1998 |
|
RU2164139C2 |
TREATING CANCER WITH COMBINATION OF RADIATION THERAPY, CERIUM OXIDE NANOPARTICLES AND CHEMOTHERAPEUTIC AGENT | 2015 |
|
RU2704811C2 |
PREPARATION POTENTIATING RADIATION THERAPY | 2007 |
|
RU2435587C2 |
Authors
Dates
2012-04-27—Published
2007-11-09—Filed